{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-26-000241","form_type":"8-K","ticker":"ACON","cik":"0001635077","company_name":"Aclarion, Inc.","filed_at":"2026-01-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.699537+00:00","generated_at":"2026-05-16T10:40:28.395431+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Aclarion closes $10.4M equity offering, reports $21.6M cash, zero debt, runway into 2028","bullets":["Closed $10.4M common-stock-only offering at $5.18/share; includes 200,000 shares and pre-funded warrants for 1.8M shares.","Cash balance $21.6M as of Jan 12, 2026; zero debt.","Cash runway extended into 2028 based on current operating plans.","Plans to accelerate CLARITY trial enrollment, launch Nociscan v2.8 in Q1'26, and pursue payer coverage.","Dawson James Securities acted as exclusive placement agent."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-26-000241","json":"https://secwatch.observer/filing/0001683168-26-000241.json","markdown":"https://secwatch.observer/filing/0001683168-26-000241.md","text":"https://secwatch.observer/filing/0001683168-26-000241.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1635077/000168316826000241/0001683168-26-000241-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1635077/000168316826000241/aclarion_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:40:28.395431+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}